ReviewBiomarker research2026

Targeted protein degradation for fetal hemoglobin induction: a new paradigm in β-hemoglobinopathy therapy.

Sanjana Arji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.